Merck KGaA (OTCMKTS:MKGAF – Get Free Report) saw an uptick in trading volume on Thursday . Approximately 601 shares traded hands during mid-day trading, a decline of 5% from the previous session’s volume of 630 shares.The stock last traded at $171.6280 and had previously closed at $167.51.
Merck KGaA Stock Up 2.9%
The firm has a market cap of $22.11 billion, a PE ratio of 26.12 and a beta of 0.96. The company has a debt-to-equity ratio of 0.27, a quick ratio of 0.84 and a current ratio of 1.31. The firm’s 50-day moving average price is $159.35 and its two-hundred day moving average price is $146.96.
Merck KGaA Company Profile
Merck KGaA, headquartered in Darmstadt, Germany, is a long-established multinational chemical and pharmaceutical company with roots dating back to 1668. Operating under the brand Merck Group (and using distinct consumer-facing names in certain regions to avoid confusion with other companies of similar name), the company is privately controlled by the Merck family and organizes its activities across multiple business units that serve customers in Europe, the Americas, Asia-Pacific and beyond.
The company’s operations are organized mainly into three businesses.
Featured Stories
- Five stocks we like better than Merck KGaA
- Why NXP Semiconductors Could Be the AI Stock Everyone Is Missing
- Powering Up: NextEra and Brookfield Build an Off-Grid Empire
- DoorDash’s Drone Certification Could Reshape Its Delivery Margins
- 2 Unique Space ETFs That Could Upend the Industry
Receive News & Ratings for Merck KGaA Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Merck KGaA and related companies with MarketBeat.com's FREE daily email newsletter.
